A state proposal to limit the number of drugs covered by Medicaid, fiercely opposed by patients and drug companies, has drawn national attention as states struggle to pay for costly new medicines.
The president has undermined the Affordable Care Act, but it “remains the law,” the administrator of the Centers for Medicare and Medicaid Services said. But she encouraged the state to keep trying.
Evaluations of state experiments “generally lacked rigor,” and the findings were often kept secret for years, so they were of little use, a government report said.
President Trump’s efforts to undermine the health law have widened the gap between those who get government aid and those who don’t, deepening resentments.
Alex M. Azar II, the health secretary, told Congress he would scrutinize Idaho’s plan to allow sale of insurance that does not comply with the Affordable Care Act.
The Independent Payment Advisory Board was supposed to make it easier for Congress to control Medicare spending. But Congress never loved it. Now it's gone.